Biotech Bombshell: MoonLake (MLTX) Shares Tumble 85% on Trial News – Is a $108 Price Target Still Real?
Sources: Company filings and press releases Globenewswire Stocktitan; financial media (Reuters, Investing.com, Stocktwits, Seeking Alpha) Reuters Stocktwits Investing; market data services Stocktitan Tipranks. All figures and quotes are from cited reports.